Article
Interstitial Page
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Eli Lilly’s Orforglipron Successfully Completes Third Phase 3 Trial Resulting in Global Regulatory Submissions
The Rx for High-Performance Leadership: Cutting Through the Chaos
Novartis, BioArctic Reach Deal to Develop BrainTransporter Therapy for Neurodegeneration
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
Genentech Breaks Ground for New Manufacturing Facility in North Carolina
U.S. CDC Elects mRNA Vaccine Critic to Lead Covid-19 Immunization Workgroup